Please provide your email address to receive an email when new articles are posted on . A combination of microencapsulated benzoyl peroxide and microencapsulated tretinoin significantly improved ...

The trial was conducted by Sagimet’s license partner for China, Ascletis Bioscience Co., in 480 patients with moderate to ...

SAN DIEGO, Feb. 11, 2020 /PRNewswire/ -- Dermata Therapeutics, LLC, a privately held biotechnology company, announced today that it has completed enrollment of patients in its Phase 2b clinical trial ...

A persistent myth is that acne results from poor hygiene. It’s an understandable assumption given that bacteria play a role, ...

A WOMAN who developed severe cystic acne as a teenager has hailed a £13 cream as a miraculous cure for her skin. The now 25-year-old developed the skin condition when she was 15 and it shattered her ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — A rapid improvement in severe acne was observed in patients treated with 12 weeks of trifarotene and ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

Active ingredients: Clindamycin (as phosphate) 1.2%, benzoyl peroxide 2.5%; gel. Indication: Topical treatment of acne vulgaris. Pharmacology: Acanya gel combines the lincosamide antibiotic, ...

Discover a study revealing how prebiotics improve acne vulgaris by balancing the skin microbiome and enhancing collagen for ...